Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Overall survival (OS) is the primary end point in phase III oncology trials. Given low success rates, surrogate end points, such as progression-free survival or objective response rate, are used in early go/no-go decision making. Here, we investigate whether early trends of OS prognostic biomarkers, such as the ROPRO and DeepROPRO, can also be used for this purpose.

Methods: Using real-world data, we emulated a series of 12 advanced non-small-cell lung cancer (aNSCLC) clinical trials, originally conducted by six different sponsors and evaluated four different mechanisms, in a total of 19,920 individuals. We evaluated early trends (until 6 months) of the OS biomarker alongside early OS within the joint model (JM) framework. Study-level estimates of early OS and ROPRO trends were correlated against the actual final OS hazard ratios (HRs).

Results: We observed a strong correlation between the JM estimates and final OS HR at 3 months (adjusted = 0.88) and at 6 months (adjusted = 0.85). In the leave-one-out analysis, there was a low overall prediction error of the OS HR at both 3 months (root-mean-square error [RMSE] = 0.11) and 6 months (RMSE = 0.12). In addition, at 3 months, the absolute prediction error of the OS HR was lower than 0.05 for three trials.

Conclusion: We describe a pipeline to predict trial OS HRs using emulated aNSCLC studies and their early OS and OS biomarker trends. The method has the potential to accelerate and improve decision making in drug development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730042PMC
http://dx.doi.org/10.1200/CCI.23.00062DOI Listing

Publication Analysis

Top Keywords

early trends
12
trends prognostic
8
non-small-cell lung
8
lung cancer
8
clinical trials
8
decision making
8
months adjusted
8
prediction error
8
early
6
months
6

Similar Publications

Introduction: the progressive increase in the volume of primary knee arthroplasty surgery is leading in parallel to an increase in revision surgeries, and this trend is expected to continue in the coming decades.

Material And Methods: a retrospective observational study with 203 interventions in 201 patients with knee arthroplasty revision surgery at our center between 2018-2022, including the variables age, sex, body mass index, primary implant, time until revision surgery, mechanical alignment of the primary implant, cause of revision, revision implant, and need for secondary revision.

Results: the average age of the patients was 73.

View Article and Find Full Text PDF

To explore the feasibility and accuracy of predicting respiratory tract infections (RTIs) using physiological data obtained from consumer-grade smartwatches. The study used smartwatches and paired mobile applications to continuously collect physiological parameters while participants slept. A personalized baseline model was established using multi-day data, followed by the construction of RTIs risk prediction algorithm based on deviations from physiological parameter trends.

View Article and Find Full Text PDF

Background: Cancer screening nonadherence persists among adults who are deaf, deafblind, and hard of hearing (DDBHH). These barriers span individual, clinician, and health care system levels, contributing to difficulties understanding cancer information, accessing screening services, and following treatment directives. Critical communication barriers include ineffective patient-physician communication, limited access to American Sign Language (ASL) cancer information, misconceptions about medical procedures, insurance navigation difficulties, and intersectional barriers for multiply marginalized individuals.

View Article and Find Full Text PDF

Objectives: This study aimed to examine physical and craniofacial growth patterns in preschool-aged children with microcephaly and evaluate their potential clinical significance.

Methods: A total of 130 children (76 boys, 54 girls) aged 1-5 years with microcephaly (head circumference <-3 standard deviations) were enrolled in this prospective study at a tertiary care hospital, with 130 age- and sex-matched healthy controls. Nine craniofacial dimensions (head circumference, head length, head width, physiognomic facial length, morphological facial length, minimum frontal diameter, bizygomatic diameter, bigonial diameter, and total jaw height) were measured every six months using standardized techniques and instruments.

View Article and Find Full Text PDF

Global prevalence, incidence and years lived with disability of polycystic ovary syndrome highlights disease burden among adolescents.

Reprod Biomed Online

May 2025

Department of Obstetrics and Gynaecology, and Neonatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Centre for Obstetrics and Gynaecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Med

Research Question: What is the global, regional and national burden of polycystic ovary syndrome (PCOS), particularly in adolescents, based on data from the Global Burden of Disease (GBD) 2021 study?

Design: Prevalence, incidence and years lived with disability (YLD) for PCOS were extracted from the GBD 2021 database, standardized via Bayesian meta-regression, and stratified by age, region and Socio-Demographic Index (SDI). Temporal trends (1990-2021) were presented, and future projections (to 2045) were modelled using autoregressive integrated moving average models.

Results: Between 1990 and 2021, the global prevalence of PCOS increased from 36.

View Article and Find Full Text PDF